Cargando…

Metabolic disruption identified in the Huntington’s disease transgenic sheep model

Huntington’s disease (HD) is a dominantly inherited, progressive neurodegenerative disorder caused by a CAG repeat expansion within exon 1 of HTT, encoding huntingtin. There are no therapies that can delay the progression of this devastating disease. One feature of HD that may play a critical role i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handley, Renee. R., Reid, Suzanne J., Patassini, Stefano, Rudiger, Skye R., Obolonkin, Vladimir, McLaughlan, Clive. J., Jacobsen, Jessie C., Gusella, James F., MacDonald, Marcy E., Waldvogel, Henry J., Bawden, C. Simon, Faull, Richard L. M., Snell, Russell G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749952/ https://www.ncbi.nlm.nih.gov/pubmed/26864449 http://dx.doi.org/10.1038/srep20681

Ejemplares similares

A Multi-Omic Huntington’s Disease Transgenic Sheep-Model Database for Investigating Disease Pathogenesis
por: Mears, Emily R., et al.
Publicado: (2021)

Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration
por: Chiang, Colby, et al.
Publicado: (2012)

Rapid and Progressive Regional Brain Atrophy in CLN6 Batten Disease Affected Sheep Measured with Longitudinal Magnetic Resonance Imaging
por: Sawiak, Stephen J., et al.
Publicado: (2015)

Metabolic profiling of presymptomatic Huntington’s disease sheep reveals novel biomarkers
por: Skene, Debra J., et al.
Publicado: (2017)

Huntington's disease: the case for genetic modifiers
por: Gusella, James F, et al.
Publicado: (2009)

Potential molecular consequences of transgene integration: The R6/2 mouse example
por: Jacobsen, Jessie C., et al.
Publicado: (2017)

Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease
por: Patassini, Stefano, et al.
Publicado: (2019)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
por: Jiang, Andrew, et al.
Publicado: (2023)

Genetic analysis of the GRIK2 modifier effect in Huntington's disease
por: Zeng, Wenqi, et al.
Publicado: (2006)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates
por: Schut, Menno H., et al.
Publicado: (2017)

Huntington’s Disease Pathogenesis: Two Sequential Components
por: Hong, Eun Pyo, et al.
Publicado: (2021)

Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains
por: Fourie, C., et al.
Publicado: (2014)

No symphony without bassoon and piccolo: changes in synaptic active zone proteins in Huntington’s disease
por: Huang, Ting-Ting, et al.
Publicado: (2020)

Cerebellar degeneration correlates with motor symptoms in Huntington disease
por: Singh‐Bains, Malvindar K., et al.
Publicado: (2019)

Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease
por: McAllister, Branduff, et al.
Publicado: (2021)

Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia
por: Reiner, Anton, et al.
Publicado: (2013)

DNA methylation study of Huntington’s disease and motor progression in patients and in animal models
por: Lu, Ake T., et al.
Publicado: (2020)

Hypomorphic mutation of the mouse Huntington’s disease gene orthologue
por: Murthy, Vidya, et al.
Publicado: (2019)

Intestinal Barrier Function and Performance of Broiler Chickens Fed Additional Arginine, Combination of Arginine and Glutamine or an Amino Acid-Based Solution
por: Barekatain, Reza, et al.
Publicado: (2021)

Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target
por: Scholefield, Melissa, et al.
Publicado: (2023)

Population-specific genetic modification of Huntington's disease in Venezuela
por: Chao, Michael J., et al.
Publicado: (2018)

Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's disease
por: Ramos, Eliana Marisa, et al.
Publicado: (2015)

MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington's Disease Pathogenesis
por: Hoss, Andrew G., et al.
Publicado: (2014)

Measurement of Spin Correlation in Top Quark Pair Production at ATLAS
por: McLaughlan, Thomas
Publicado: (2014)

Controllable Nucleation of Cavitation from Plasmonic Gold Nanoparticles for Enhancing High Intensity Focused Ultrasound Applications
por: McLaughlan, James R.
Publicado: (2018)

Targeting the Cholinergic System to Develop a Novel Therapy for Huntington’s Disease
por: D’Souza, Gary X., et al.
Publicado: (2016)

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression
por: Labadorf, Adam, et al.
Publicado: (2015)

Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression
por: Labadorf, Adam, et al.
Publicado: (2016)

miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement
por: Hoss, Andrew G, et al.
Publicado: (2015)

An analysis of the relationship between serum cortisol and serum sodium in routine clinical patients
por: McLaughlan, Eleanor, et al.
Publicado: (2017)

Lung ultrasound education: simulation and hands-on
por: Wolstenhulme, Stephen, et al.
Publicado: (2021)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
por: Chen, Xi, et al.
Publicado: (2011)

Lessons Learned from the Transgenic Huntington's Disease Rats
por: Vlamings, Rinske, et al.
Publicado: (2012)

Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
por: Lobanov, Sergey V., et al.
Publicado: (2022)

Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels
por: Horvath, Steve, et al.
Publicado: (2016)

Gold Nanorods for Light-Based Lung Cancer Theranostics
por: Knights, Oscar B., et al.
Publicado: (2018)

Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder
por: Xu, Jingshu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9uagq9u70amebfamu86o3of0ii